Back to companies

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Hanmi Science Co Ltd (Hanmi Science) is a healthcare company that researches and develops pharmaceutical products. The company offers health functional food products for liver, bone and joint care, eye health, gut and intestines, and blood circulation conditions. Hanmi Science offers medical devices that comprise nasal packing agents, goal replacement systems, soft tissue adhesives, anti-adhesion agents, styptics and diagnostic tools. The company also offers cosmetics and skincare products. It markets its products under the brands RESORBA, Q-Guard, Epistax, LIQUIBAND and KOLLAGEN resorb, among others. The company operates in the UK, South Korea, Japan, and China. Hanmi Science is headquartered in Hwaseong, Gyeonggi, South Korea.

Gain a 360-degree view of Hanmi Science Co Ltd and make more informed decisions for your business Gain a 360-degree view of Hanmi Science Co Ltd and make more informed decisions for your business Register your interest
Headquarters South Korea

Address Paltan Industrial Complex, 214, Muha-Ro, Paltan-Myeon, Hwaseong, 18536


Telephone 82 2 4109114

No of Employees 98

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 008930 (KRX)

Revenue (2024) $955.0M 5.7% (2024 vs 2023)

EPS XYZ

Net Income (2024) XYZ 99.2% (2024 vs 2023)

Market Cap* $1.7B

Net Profit Margin (2024) XYZ 88.3% (2024 vs 2023)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Hanmi Science Co Ltd premium industry data and analytics

300+

Clinical Trials

Determine Hanmi Science Co Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

260+

Marketed Drugs

Understand Hanmi Science Co Ltd’s commercialized product portfolio to stay one step ahead of the market.

140+

Pipeline Drugs

Identify which of Hanmi Science Co Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

120+

Catalyst Calendar

Proactively evaluate Hanmi Science Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

100+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Hanmi Science Co Ltd’s relevant decision makers and contact details.

20+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

17+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Hanmi Science Co Ltd and assess market opportunity for new entrants with patient population 8-year forecasts.

8

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Hanmi Science Co Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Brands
Healthcare Functional Products RESORBA
Soy Milk Q-Guard
General Food Products Epistax
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Hanmi Science Co Ltd portfolio and identify potential areas for collaboration Understand Hanmi Science Co Ltd portfolio and identify potential areas for collaboration Register your interest

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2025 New Products/Services In September, the company launched Hanmi CareMe, a premium nutritional supplement for seniors.
2024 New Products/Services In December, the company introduced Complete Soymilk Bone-Strengthening Black Bean High Calcium.
2024 New Products/Services In July, the company's Online Pharm introduced an AI demand‑forecasting solution.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Register your interest
Image for loader

Competitor Comparison

Key Parameters Hanmi Science Co Ltd Easy Holdings Co Ltd Chong Kun Dang Pharmaceutical Corp. Daewoong Pharmaceutical Co Ltd JW Holdings Corp
Headquarters South Korea South Korea South Korea South Korea South Korea
City Hwaseong Seoul Seoul Hwaseong Gwacheon
State/Province - - Seoul - Seoul
No. of Employees 98 142 2,336 1,749 128
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Choi Hyun Man Chairman Executive Board 2025 65
Kim Jae kyo Vice Chairman; Chief Executive Officer Executive Board 2025 59
Lim Ju Hyeon Vice Chairman Executive Board 2025 52
Shim Byeong Hwa Vice President; Director; Chief Financial Officer Executive Board 2025 58
Kim Seong Hoon Director Non Executive Board 2025 48
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Hanmi Science Co Ltd key executives to enhance your sales strategy Gain insight into Hanmi Science Co Ltd key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?